CD44 and neoplasm: CD44 gene knockout can increase the chemosensitivity of ovarian cancer cells to paclitaxel and inhibit tumor growth (7), and targeted inhibition of CD44 gene expression combined with chemotherapy drugs may be a more effective strategy for ovarian cancer treatment.